{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T19:02:09Z","timestamp":1789239729287,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["PID2019-105645RB-I00"],"award-info":[{"award-number":["PID2019-105645RB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["PID2023-150168NB-I00"],"award-info":[{"award-number":["PID2023-150168NB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["PID2022-139930NB-I00"],"award-info":[{"award-number":["PID2022-139930NB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.clinph.2025.2110781","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T11:17:03Z","timestamp":1749208623000},"page":"2110781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cognitive effects of a single dose of methylphenidate in Parkinson\u2019s disease patients using electrophysiological measures"],"prefix":"10.1016","volume":"176","author":[{"given":"Noa","family":"Fogelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela Martinez","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirian Roson","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Fernandez-del-Olmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Gurevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia Vela","family":"Desojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinph.2025.2110781_b0005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.biopsycho.2018.02.011","article-title":"Methylphenidate selectively modulates one sub-component of the no-go P3 in pediatric ADHD medication responders","volume":"134","author":"Aasen","year":"2018","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.clinph.2025.2110781_b0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00002826-200601000-00005","article-title":"Effects of methylphenidate on cognitive function and gait in patients with Parkinson\u2019s disease: a pilot study","volume":"29","author":"Auriel","year":"2006","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.clinph.2025.2110781_b0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/WNF.0b013e318170576c","article-title":"Methylphenidate for the treatment of Parkinson disease and other neurological disorders","volume":"32","author":"Auriel","year":"2009","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.clinph.2025.2110781_b0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40263-021-00883-0","volume":"36","author":"Azhar","year":"2022","journal-title":"Pharmacological Management of Apathy in Dementia CNS Drugs"},{"key":"10.1016\/j.clinph.2025.2110781_b0025","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1469-7610.2007.01760.x","article-title":"Effects of methylphenidate on working memory components: influence of measurement","volume":"48","author":"Bedard","year":"2007","journal-title":"J Child Psychol. Psychiatry"},{"key":"10.1016\/j.clinph.2025.2110781_b0030","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2007.01623.x","article-title":"Can methylphenidate reduce fall risk in community-living older adults? a double-blind, single-dose cross-over study","volume":"56","author":"Ben-Itzhak","year":"2008","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.clinph.2025.2110781_b0035","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.neubiorev.2012.11.005","article-title":"Psychostimulants and motivated behavior: arousal and cognition","volume":"37","author":"Berridge","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.clinph.2025.2110781_b0040","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.biopsych.2006.04.022","article-title":"Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function","volume":"60","author":"Berridge","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.clinph.2025.2110781_b0045","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.nicl.2018.10.027","article-title":"A comparative study on the neurophysiological mechanisms underlying effects of methylphenidate and neurofeedback on inhibitory control in attention deficit hyperactivity disorder","volume":"20","author":"Bluschke","year":"2018","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.clinph.2025.2110781_b0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0166-2236(90)90058-I","article-title":"Cognitive function in Parkinson\u2019s disease: from description to theory","volume":"13","author":"Brown","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.clinph.2025.2110781_b0055","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/jnnp.47.5.454","article-title":"Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson\u2019s disease","volume":"47","author":"Brown","year":"1984","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clinph.2025.2110781_b0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00002826-200107000-00003","article-title":"Methylphennidate increases the motor effects of L-dopa in PD: a pilot study","volume":"24","author":"Camicioli","year":"2001","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.clinph.2025.2110781_b0065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fnagi.2019.00303","article-title":"Parkinson's disease-mild cognitive impairment (PD-MCI): a useful summary of update knowledge","volume":"11","author":"Cammisuli","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.clinph.2025.2110781_b0070","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s40261-019-00830-4","article-title":"Comprehensive real-world assessment of marketed medications to guide Parkinson's drug discovery","volume":"39","author":"Cepeda","year":"2019","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.clinph.2025.2110781_b0075","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/cercor\/11.12.1136","article-title":"Enhanced or impaired cognitive function in Parkinson\u2019s disease as a function of dopaminergic medication and task demands","volume":"11","author":"Cools","year":"2001","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.clinph.2025.2110781_b0080","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.gaitpost.2014.10.022","article-title":"Gait and attentional performance in freezers under methylphenidate","volume":"41","author":"Delval","year":"2015","journal-title":"Gait Posture"},{"key":"10.1016\/j.clinph.2025.2110781_b0085","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/jnnp.2006.100016","article-title":"Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson\u2019s disease","volume":"78","author":"Devos","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clinph.2025.2110781_b0090","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.clinthera.2013.08.011","article-title":"New pharmacological options for treating advanced Parkinson's disease","volume":"35","author":"Devos","year":"2013","journal-title":"Clin. Ther."},{"key":"10.1016\/j.clinph.2025.2110781_b0095","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.neuroimage.2004.11.023","article-title":"Executive dysfunction in Parkinson\u2019s disease is associated with altered pallidal-frontal processing","volume":"25","author":"Direnberg","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.clinph.2025.2110781_b0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jns.2012.07.015","article-title":"The role of the dopaminergic system in mood, motivation and cognition in Parkinson's disease: a double blind randomized placebo-controlled experimental challenge with pramipexole and methylphenidate","volume":"320","author":"Drijgers","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clinph.2025.2110781_b0105","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.biopsych.2017.04.016","article-title":"The effects of methylphenidate on the neural signatures of sustained attention","volume":"82","author":"Dockree","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.clinph.2025.2110781_b0110","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clinph.2025.2110781_b0115","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1212\/WNL.0b013e3182143537","article-title":"Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial","volume":"76","author":"Espay","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2025.2110781_b0120","series-title":"Recent Developments in Parkinson\u2019s Disease","first-page":"153","article-title":"Unified Parkinson\u2019s disease rating scale","author":"Fahn","year":"1987"},{"key":"10.1016\/j.clinph.2025.2110781_b0125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neubiorev.2015.02.016","article-title":"Neural correlates of local contextual processing across stimulus modalities and patient populations","volume":"52","author":"Fogelson","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.clinph.2025.2110781_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bandc.2021.105773","article-title":"Altered directed connectivity during the processing of implicit versus explicit predictive stimuli in Parkinson\u2019s disease patients","volume":"152","author":"Fogelson","year":"2021","journal-title":"Brain Cogn."},{"key":"10.1016\/j.clinph.2025.2110781_b0135","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.clinph.2010.07.017","article-title":"Contextual processing deficits in Parkinso\u0144s disease: role of the frontostriatal system","volume":"122","author":"Fogelson","year":"2011","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.clinph.2025.2110781_b0140","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bandc.2013.05.001","article-title":"Functional connectivity during contextual processing in schizophrenia and Parkinson\u2019s disease","volume":"8","author":"Fogelson","year":"2013","journal-title":"Brain Cogn."},{"key":"10.1016\/j.clinph.2025.2110781_b0145","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1093\/brain\/awp230","article-title":"Prefrontal cortex is critical for contextual processing: evidence from brain lesions","volume":"132","author":"Fogelson","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.clinph.2025.2110781_b0150","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1037\/0894-4105.10.3.321","article-title":"Reduced working memory span in Parkinson\u2019s disease: evidence for the role of a frontostriatal system in working and strategic memory","volume":"10","author":"Gabrieli","year":"1996","journal-title":"Neuropsychology"},{"key":"10.1016\/j.clinph.2025.2110781_b0155","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1037\/a0023165","article-title":"Molecular modulation of prefrontal cortex: rational development of treatments for psychiatric disorders","volume":"125","author":"Gamo","year":"2011","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.clinph.2025.2110781_b0160","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression, and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2025.2110781_b0165","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1093\/brain\/awz149","article-title":"Stratifying drug treatment of cognitive impairments after traumatic brain injury using neuroimaging","volume":"142","author":"Jenkins","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.clinph.2025.2110781_b0170","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.brs.2022.04.019","article-title":"Methylphenidate effects on a clinically informative oscillatory signal within the subthalamic nucleus in Parkinson's disease during deep brain stimulation programming","volume":"15","author":"Kern","year":"2022","journal-title":"Brain Stimul."},{"key":"10.1016\/j.clinph.2025.2110781_b0175","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00002512-200016050-00006","article-title":"Role of dopamine in learning and memory","volume":"16","author":"Kulisevsky","year":"2000","journal-title":"Drugs Aging"},{"key":"10.1016\/j.clinph.2025.2110781_b0180","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13195-019-0567-z","article-title":"Methylphenidate and galantamine in patients with vascular cognitive impairment-the proof-of-principle study STREAM-VCI","volume":"12","author":"Leijenaar","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.clinph.2025.2110781_b0185","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0028-3932(02)00257-9","article-title":"Using executive heterogeneity to explore the nature of working memory deficits in Parkinson\u2019s disease","volume":"41","author":"Lewis","year":"2003","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.clinph.2025.2110781_b0190","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1523\/JNEUROSCI.23-15-06351.2003","article-title":"Cognitive impairments in early Parkinson\u2019s disease are accompanied by reductions in activity in frontostriatal neural circuitry","volume":"23","author":"Lewis","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clinph.2025.2110781_b0195","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.neuropsychologia.2004.10.001","article-title":"Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson\u2019s disease","volume":"43","author":"Lewis","year":"2005","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.clinph.2025.2110781_b0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuropsychologia.2017.12.006","article-title":"Processing of implicit versus explicit predictive contextual information in Parkinson's disease","volume":"109","author":"Li","year":"2018","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.clinph.2025.2110781_b0205","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.euroneuro.2013.09.009","article-title":"Cognitive effects of methylphenidate and levodopa in healthy volunteers","volume":"24","author":"Linssen","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.clinph.2025.2110781_b0210","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00213-011-2345-x","article-title":"Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidate","volume":"218","author":"Linssen","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.clinph.2025.2110781_b0215","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1469-7610.2004.00221.x","article-title":"Methylphenidate improves working memory and set-shifting in AD\/HD: relationships to baseline memory capacity","volume":"45","author":"Mehta","year":"2004","journal-title":"J Child Psychol. Psychiatry"},{"key":"10.1016\/j.clinph.2025.2110781_b0220","doi-asserted-by":"crossref","first-page":"RC65","DOI":"10.1523\/JNEUROSCI.20-06-j0004.2000","article-title":"Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain","volume":"20","author":"Mehta","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clinph.2025.2110781_b0225","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1474-4422(12)70106-0","article-title":"Parkgait-II study group. methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial","volume":"11","author":"Moreau","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clinph.2025.2110781_b0230","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1002\/hbm.22557","article-title":"The effects of methylphenidate on whole brain intrinsic functional connectivity","volume":"35","author":"Mueller","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.clinph.2025.2110781_b0235","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.887923","article-title":"Augmenting mental chronometry: the P300 as a measure of stimulus evaluation time","volume":"197","author":"Kutas","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.clinph.2025.2110781_b0240","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.clinph.2025.2110781_b0245","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archneur.64.3.319","article-title":"Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial","volume":"64","author":"Nutt","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.clinph.2025.2110781_b0250","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/ana.20089","article-title":"The dopamine transporter: importance in Parkinson's disease","volume":"55","author":"Nutt","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clinph.2025.2110781_b0255","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/1073858404266776","article-title":"Cognitive dysfunction in Parkinson\u2019s disease: the role of frontostriatal circuitry","volume":"6","author":"Owen","year":"2004","journal-title":"Neuroscientist"},{"key":"10.1016\/j.clinph.2025.2110781_b0260","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/1049909111427029","article-title":"Methylphenidate: established and expanding roles in symptom management","volume":"29","author":"Prommer","year":"2012","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"10.1016\/j.clinph.2025.2110781_b0265","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/archneur.57.4.470","article-title":"Cognitive impairment and the brain dopaminergic system in Parkinson\u2019s disease","volume":"57","author":"Rinne","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.clinph.2025.2110781_b0270","doi-asserted-by":"crossref","first-page":"9547","DOI":"10.1523\/JNEUROSCI.1746-16.2016","article-title":"Methylphenidate modulates functional network connectivity to enhance attention","volume":"36","author":"Rosenberg","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clinph.2025.2110781_b0275","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.biopsych.2014.09.013","article-title":"The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortex","volume":"77","author":"Spencer","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.clinph.2025.2110781_b0280","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00213-003-1457-3","article-title":"Relative lack of cognitive effects of methylphenidate in elderly male volunteers","volume":"168","author":"Turner","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.clinph.2025.2110781_b0285","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/brain\/awm111","article-title":"Evolution of cognitive dysfunction in an incident Parkinson\u2019s disease cohort","volume":"130","author":"Williams-Gray","year":"2007","journal-title":"Brain"}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245725006339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245725006339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T14:21:31Z","timestamp":1757773291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388245725006339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":57,"alternative-id":["S1388245725006339"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2025.2110781","relation":{},"ISSN":["1388-2457"],"issn-type":[{"value":"1388-2457","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive effects of a single dose of methylphenidate in Parkinson\u2019s disease patients using electrophysiological measures","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2025.2110781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"2110781"}}